What to Check on a Stem Cell Conditioned Media Certificate of Analysis (CoA) — A Practical Guide for Hair Regenerative Medicine, Organized by Dr. Moriwaki2026.07.22

“I was recommended stem cell conditioned media treatment at a clinic, but is the product really safe and properly quality-controlled?” — this is one of the questions we hear most often from patients considering hair regenerative medicine. The document that grounds that confidence is the Certificate of Analysis (CoA) issued by the manufacturer for each lot. In this article, Dr. Moriwaki, who supervises hair regenerative medicine at AVAN TOKYO Ginza, organizes how to actually read a stem cell conditioned media CoA and what to verify, in a form patients can use directly in the consultation room.

Key Points of This Article

・A stem cell conditioned media CoA is an official record that summarizes the manufacturing conditions and quality-testing results for each lot.

・The three items “sterility test / mycoplasma negative / endotoxin within specification” form the foundation of safety and must always be confirmed.

・Cell source (umbilical cord, adipose, dental pulp), passage number, and culture conditions are also decision-making inputs when choosing an injectable for the scalp.

・Content values for growth factors and exosome particle counts are not “more is better”; assay method and reproducibility must be read together.

・Do not decide simply because the judgment column says “pass”; reading the distance between specification and measured value raises the quality of your hair treatment.

What Is a Stem Cell Conditioned Media CoA — A Quality Record You Can’t Afford to Overlook in Hair Regenerative Medicine

Stem cell conditioned media is the liquid fraction that remains after culturing mesenchymal stem cells, containing growth factors, cytokines, and exosomes. It does not contain the cells themselves — the secreted molecules take center stage. Because manufacturing conditions and cell state vary subtly between lots, a CoA is issued to guarantee quality. Predefined items such as sterility, endotoxin level, and protein concentration are tested, and results are recorded as numerical values and judgments.

A Quality Passport Connecting Patient and Physician

Which manufacturing facility, which lot, and which tests the injectable that enters your scalp has passed through — the CoA is the official document that lets you trace this. It is a fundamental piece supporting transparency in hair regenerative medicine, ensuring that root causes can be traced should an adverse event ever occur. For the medical framework around AGA and other hair-loss conditions, the guidelines from the Japanese Dermatological Association are worth cross-referencing.

Three Safety Items You Must Always Check on a Stem Cell Conditioned Media CoA

Sterility / Mycoplasma / Endotoxin

The first three items to verify are: sterility test, negative mycoplasma result, and endotoxin within specification. These form the safety foundation indispensable when injecting into the scalp, an area sensitive to infection. Endotoxin especially is ideally listed with both a specification value (EU/mL, etc.) and a measured value. It is an endotoxin left behind when bacteria die and can cause fever and local inflammation even in trace amounts, so a CoA that lets you see the number is preferable.

Cell Source and Passage Number

Studies report that the growth-factor profile in the conditioned media varies with the cell source — umbilical cord, adipose, or dental pulp. If the CoA explicitly lists “cell source” and “passage number,” that is a sign of traceability. It is also known that the profile of secreted proteins changes as passage number increases, making it a useful input when assessing clinical reproducibility. Because no source can be declared categorically superior, the first step is simply to confirm that these fields are filled in.

Specification, Measured Value, Judgment — Only When You Read All Three Have You “Seen the Quality”

Even if the judgment column reads “pass,” being reassured by that alone is premature. A CoA is best read in three tiers: (1) specification (acceptance criterion), (2) measured value, (3) judgment. Read this way, lot-to-lot quality variability comes into three-dimensional view. This is the basic protocol for using a stem cell conditioned media CoA as decision-making material in clinical practice.

“Barely Within Spec” or “Well Within Spec”

For example, if the endotoxin specification is ≤0.5 EU/mL, the meaning changes dramatically depending on whether the measured value is 0.48 or 0.05 EU/mL. Considering long-term stability and variations in transport temperature, lots that sit well within specification are preferred from a clinical operations perspective. Looking not just at the raw number but at the distance from the specification adds depth to how safety is explained to patients.

Do Not Confuse “n.d.” with “Not Measured”

“n.d.” (Not Detected) and “Not Measured” mean completely different things. The former means testing was done and the result was below the detection limit; the latter means testing was not performed at all. A CoA that leaves this ambiguous invites misunderstandings when explaining to patients. Simply asking the physician “what was measured and what was not” changes how quality appears.

How to Interpret Content Values for Growth Factors and Exosomes

An increasing number of CoAs quantify growth factors such as VEGF, IGF-1, and HGF, as well as exosome particle counts. However, “more is better” is not a straightforward relationship — numbers vary greatly by assay method (ELISA, NTA, TRPS, etc.) and sample dilution conditions. Rather than taking numbers at face value, checking reproducibility across the same process and same lot alongside them is the literacy of reading a stem cell conditioned media CoA. Because clinical outcomes also vary with the sensitivity of individual hair follicles and the state of the hair cycle, treating content values as one input among several is the honest position.

A Practical Checklist for Reviewing a Stem Cell Conditioned Media CoA at Your First Visit

Questions to Ask in the Consultation Room

“May I see the CoA for the lot you plan to administer today?” — being able to say this one line changes the patient’s stance dramatically. Look through the manufacturer, manufacturing date, expiration date, storage temperature, and test items, and ask for an explanation of anything unclear on the spot. A conscientious clinic will regard sharing and explaining the CoA as an obvious responsibility. Conversely, if you sense reluctance to disclose or avoidance of explanation, that itself is grounds to consider a second opinion at another clinic.

Keeping Records When Continuing Treatment

If multiple treatment sessions are planned, it is advisable to record the administered lot number in the chart each time. Linking outcomes and adverse events with lots helps guide the next treatment plan. You can also browse our related columns on hair regenerative medicine for a systematic understanding of treatment design.

Frequently Asked Questions

Q. Can a patient actually ask to see the CoA?

Yes. In principle, more and more medical institutions have systems in place to disclose it upon patient request. Because facilities using specified processed cell products are legally required to file notifications and preserve records, being told the CoA cannot be shown is unnatural. Please try asking during your consultation first.

Q. Is it enough if the CoA just says “Sterility Test: Pass”?

That meets the minimum, but more thorough CoAs also list the test method, testing laboratory, and measured value. The same applies to endotoxin and mycoplasma — the single word “pass” is somewhat thin as a decision-making input. If possible, choosing a manufacturing route that provides CoAs with measured values will increase your peace of mind.

Q. Does a lot with higher growth-factor content grow more hair?

The magnitude of the number and the clinical effect are not simply proportional. Effects depend on differences in assay method, the state of the individual’s hair follicles, and the combinations and microenvironments in which growth factors work. Content values should be treated as one reference point, evaluated together with the overall treatment design. Individual variability and the limits of indication must always be kept in mind.

Q. Why do some hair-regenerative-medicine CoAs have “unlisted” items?

Test items are chosen based on each manufacturing facility’s quality control plan, and beyond the legally mandated items, the selection varies by facility. That said, if basic safety items such as sterility, mycoplasma, or endotoxin are missing, ask the treating physician why. If no reasonable explanation is provided, it may be time to widen your options.

Q. Is it dangerous to receive treatment without checking the CoA?

The document does not reduce risk to zero, but there is a large difference between having and not having a system that lets quality be traced. Especially for scalp injection therapy, avoiding infection and inflammation is a central concern, so choosing a facility with a proper CoA disclosure and record-keeping system carries meaning as a patient’s own line of defense.

──────────────

【Supervisor】Shin Moriwaki, MD (Supervising Physician)

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate

──────────────

📍AVAN TOKYO Ginza Hair Regenerative Medicine

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt supported

Inquiries welcome via DM / LINE / Website / Phone.